Post by PulmoBioMed Ltd.

PulmoBioMed Opens Investment Round to Accelerate Commercial Growth PulmoBioMed is pleased to announce the opening of our latest investment round as we enter a pivotal stage of commercial expansion. Following key milestones including CE marking, FDA registration, manufacturing readiness, and growing international market interest, we are now seeking strategic investment partners to help accelerate adoption of our first-in-class deep lung breath sampling technology. Our platform enables access to saliva-free samples from lower respiratory, non-invasively, creating new opportunities across diagnostics, clinical research, pharmaceutical development, and patient monitoring. With respiratory disease affecting over 1 billion people globally, the need for faster, more accessible, and more scalable lung sampling solutions has never been greater. This raise will support: • Commercial scale-up across key markets • Expansion of strategic partnerships • Clinical evidence generation • New applications across respiratory medicine and beyond We welcome conversations with investors who share our vision for transforming respiratory healthcare through innovation. To learn more or request our investor materials, please contact us 👉 https://lnkd.in/eZgAz8Zu #Investment #MedTech #HealthTech #Diagnostics #RespiratoryHealth #Innovation #LifeSciences #Startups #VentureCapital #Investor #ScaleUp